Verbeuren T J, Koenig-Bérard E, Jordaens F H, Van Hoydonck A E, Verrelst J, Zonnekeyn L L, Herman A G
Institut de Recherches Servier, Suresnes, France.
Arch Int Pharmacodyn Ther. 1989 Jul-Aug;300:114-39.
In several blood vessels, the influence of the alpha 2-adrenoceptor agonists rilmenidine and clonidine was compared. In aortas of rat and rabbit and in the rabbit pulmonary artery, both compounds evoked contractions due to stimulation of postjunctional alpha 1-adrenoceptors. In the aorta of the rat, but not in that of the rabbit, removal of the endothelium markedly enhanced the contractions to rilmenidine and clonidine. At the alpha 1-adrenoceptors, clonidine was about 135 times more potent than rilmenidine. The activity of both substances at post- and prejunctional alpha 2-adrenoceptors was compared in the rabbit saphenous vein. Rilmenidine and clonidine evoked contractions of the vein by stimulating postjunctional alpha 2-adrenoceptors and decreased the stimulation-induced overflow of [3H]-noradrenaline by activating the prejunctional alpha 2-adrenoceptors. At the post- and prejunctional alpha 2-adrenoceptors, clonidine was about 30 times more potent than rilmenidine. These data illustrate that, although less potent than clonidine, rilmenidine is 5 times more specific for the alpha 2-adrenoceptors. In the isolated perfused rat kidney, rilmenidine and clonidine antagonized the vasoconstrictions induced by noradrenaline. Although the exact mechanism of this inhibitory response remains to be elucidated, our results indicate that rilmenidine may possess some interesting properties at the level of the renal circulation.
在几条血管中,比较了α2-肾上腺素能受体激动剂利美尼定和可乐定的影响。在大鼠和兔子的主动脉以及兔子肺动脉中,这两种化合物均通过刺激节后α1-肾上腺素能受体引起收缩。在大鼠主动脉中,而非兔子主动脉中,去除内皮显著增强了对利美尼定和可乐定的收缩反应。在α1-肾上腺素能受体处,可乐定的效力比利美尼定强约135倍。在兔子隐静脉中比较了这两种物质在节后和节前α2-肾上腺素能受体上的活性。利美尼定和可乐定通过刺激节后α2-肾上腺素能受体引起静脉收缩,并通过激活节前α2-肾上腺素能受体减少刺激诱导的[3H]-去甲肾上腺素溢出。在节后和节前α2-肾上腺素能受体处,可乐定的效力比利美尼定强约30倍。这些数据表明,尽管利美尼定的效力比可乐定弱,但其对α2-肾上腺素能受体的特异性是可乐定的5倍。在离体灌注的大鼠肾脏中,利美尼定和可乐定拮抗去甲肾上腺素诱导的血管收缩。尽管这种抑制反应的确切机制仍有待阐明,但我们的结果表明利美尼定在肾循环水平可能具有一些有趣的特性。